Lifestance Health Group, Inc. Stock Price, News & Analysis

LifeStance Health Group (NASDAQ: LFST) is set to join the Russell 2000 Index effective September 20, 2021, as confirmed by the preliminary IPO additions. This marks a significant milestone for the company, which transitioned to public status earlier in 2021. The Russell 2000 Index is crucial as it is referenced for benchmarking by investment managers with around $10.6 trillion in assets linked to it. CEO Michael Lester expressed optimism that this inclusion will enhance investor awareness of the company's mission to improve access to personalized mental healthcare.

LifeStance Health Group (NASDAQ: LFST), a leading provider of outpatient mental health care, will be presenting at the Morgan Stanley Global Healthcare Conference on September 13, 2021. Key executives, including CEO Michael Lester, CFO J. Michael Bruff, and Chief Growth Officer Danish Qureshi, will participate in a fireside chat at 2:00 p.m. ET. The event will be accessible via a live webcast on their investor relations site, with a recording available afterward. LifeStance Health operates over 450 centers across 31 states, employing around 4,000 mental health professionals.

LifeStance Health (NASDAQ: LFST) announced on August 24, 2021, the appointment of Seema Verma, former administrator of the Centers for Medicare & Medicaid Services, to its Board of Directors. With over two decades of healthcare experience, Verma aims to enhance access to mental health care at a time when demand is increasing. Her previous role included overseeing health insurance for over 140 million Americans and advancing telehealth initiatives during the COVID-19 pandemic. LifeStance Health operates across 31 states with nearly 4,000 mental health professionals.

LifeStance Health (NASDAQ: LFST) has announced the expansion of its mental health services into Maryland, Michigan, Minnesota, South Carolina, and Wisconsin, raising its operational footprint to 31 states. The company aims to provide accessible mental health care to nearly 33 million additional residents, bringing its total reach to over 280 million people. LifeStance continues to prioritize affordable, personalized mental health services while accepting most commercial insurance plans, catering to increasing patient demand.

LifeStance Health reported significant growth in Q2 2021, achieving $160.5 million in revenue, a 91% increase year-over-year. The company added 674 clinicians and opened 35 new centers. Despite a net loss of $70.0 million, adjusted EBITDA rose to $14.5 million, reflecting a 39% increase. Following its IPO on June 10, 2021, LifeStance utilized $548.9 million in net proceeds for debt repayment and growth initiatives. Full-year guidance estimates revenue between $668 million and $678 million, indicating robust demand for mental health services amidst expanding clinician availability.

LifeStance Health Group Inc. (NASDAQ: LFST) will release its second quarter earnings on August 11, 2021, after market close. A live earnings conference call is scheduled for the same day at 5:00 p.m. Eastern Time. Participants can join via a dedicated phone line or through a real-time audio webcast available on the LifeStance Investor Relations website. Founded in 2017, LifeStance is a leading provider of outpatient mental health care in the U.S., employing over 3,300 professionals across 27 states.

LifeStance Health Group announced the successful closing of its initial public offering, selling 40 million shares of common stock at $18.00 per share. The company offered 32.8 million shares while selling stockholders contributed 7.2 million shares. The underwriters have an option to purchase an additional 6 million shares within 30 days. LifeStance Health, a leading provider of outpatient mental health care, trades on the Nasdaq under the ticker symbol LFST.

LifeStance Health has priced its initial public offering (IPO) at $18.00 per share, offering a total of 40 million shares. Of these, 32.8 million shares are offered by the Company, and 7.2 million shares are from selling stockholders. The IPO will trade on Nasdaq under the ticker symbol LFST starting June 10, 2021, with the offering expected to close on June 14, 2021. Proceeds will be used to repay existing debt and general corporate purposes. Lead underwriters include Morgan Stanley and Goldman Sachs.